Enovis CAO Oliver Engert Purchases 7,598 Shares Amid Financial Turnaround
Enovis CAO Oliver Engert adds 7,598 shares to his stake in the medical device firm, highlighting management's optimism as the company works…
Enovis CAO Oliver Engert adds 7,598 shares to his stake in the medical device firm, highlighting management's optimism as the company works…
CooperCompanies shares tumbled 14% as weak Q4 guidance and the decision to retain the CooperSurgical unit dashed investor hopes for a strategic…
Cooper Companies posted solid Q3 results with record free cash flow, opting to retain its CooperSurgical unit while navigating inventory-related growth constraints…
CooperCompanies beat Q3 earnings estimates despite intentional U.S. inventory reductions, while the board officially ended its strategic review of CooperSurgical to focus…
Edwards Lifesciences shows bullish momentum with raised 2026 sales guidance and a Strong Buy rating, despite trailing the broader Dow Jones index…